VestGen Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VestGen Advisors's LLY Position: Q3 2026 in Review
VestGen Advisors reduced its Eli Lilly (LLY) stake by 4.3% in Q3 2026, selling an estimated $649K and leaving 12,221 shares worth $14.1M. The position accounts for 0.44% of the portfolio, ranked #47.
VestGen Advisors first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. The position peaked at $15.3M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- VestGen Advisors held 12,221 shares of Eli Lilly worth $14.1M as of Q3 2026.
- VestGen Advisors sold 550 Eli Lilly shares in Q3 2026, an estimated $649K.
- Eli Lilly made up 0.44% of VestGen Advisors's portfolio in Q3 2026, its #47 holding.
- VestGen Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
- VestGen Advisors's Eli Lilly position peaked at $15.3M in Q2 2026.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on VestGen Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.